Correction {#Sec1}
==========

After publication of this Research Article \[[@CR1]\], we noted errors in Table [1](#Tab1){ref-type="table"}, and in the rate of thromboembolic events (page 7). Specifically, in Table [1](#Tab1){ref-type="table"} the percentage of female and male patients were incorrectly given as 7% and 3% respectively. The correct figures are 48.6% female and 51.4% male (please see a corrected version of Table [1](#Tab1){ref-type="table"} below, and the Additional file [1](#MOESM1){ref-type="media"}). The correct rate of thromboembolic events is 3.49% (originally stated as 3.55%).Table 1**Patient demographics**CharacteristicValueAge, mean ± SD (years)66.49 ± 11.77Patients with solid tumours, mean (years)65.76Patients with lymphoma, mean (years)68.59Patients with myeloma, mean (years)70.65Female (%)48.6Male (%)51.4Hb, mean ± SD (g/dL)9.59 ± 0.88sBP, mean ± SD (mmHg)125.75 ± 14.48dBP, mean ± SD (mmHg)74.18 ± 9.79Malignancies, n (%)2310 (100)Solid tumours, n (%)1838 (79.57)Lymphoma, n (%)301 (13.03)Myeloma, n (%)171 (7.40)Height, mean ± SD (cm)166.35 ± 8.72Weight, mean ± SD (kg)67.46 ± 14.23BMI, mean ± SD (kg/m^2^)24.33 ± 4.62*BMI* body mass index, *dBP* diastolic blood pressure, *Hb* haemoglobin, *sBP* systolic blood pressure, *SD* standard deviation.
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Additional file 1: **Corrected version of article** ***BMC Cancer*** **14:503.** (PDF 433 KB)

The online version of the original article can be found at 10.1186/1471-2407-14-503
